Volume 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress                   Multidiscip Cancer Investig 2017, 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress: 0-0 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Eshaghi F, Zarrin Pour V, Abdollahi A, Mohammadpour H. Overexpression FAT4 & Down Regulation NAT2 in Human Breast Cancer. Multidiscip Cancer Investig 2017; 1
URL: http://mcijournal.com/article-1-129-en.html
Abstract:   (5016 Views)
Introduction: Nowadays, cancer is known as one of the major problems of human society and scientists and researchers are looking for short and very effective ways to identify and treat this group of diseases. One of these ways to investigate specific genes in pathways that can be used to identify cancer-specific biomarkers, containing expression FAT4 and NAT2 in breast cancer and the effect on the signaling pathway in human cells. Because of the comparison high frequency of some FAT4 and NAT2 genotypes in the population, the Attributable cancer risk might be high. The effect of FAT4 and NAT2 genotype on cancer risk varies with organ location, maybe reflecting tissue-specific expression of FAT4 and NAT2.
Materials and Methods: Here we took 25 tumor samples and adjacent normal tissue of Iran National tumor Bank, we found the up regulation FAT4 and down regulation NAT2.
Results: There is no evidence for the relation between FAT4 and NAT2 (P>0.05).
Conclusions: The results propose there is an interaction between FAT4 genotype with P53 signaling pathway (P <0.05).
Full-Text [PDF 61 kb]   (1391 Downloads)    
Select article type: Original/Research Article | Subject: Materials Science and Nanomedicine
Received: 2017/10/30 | Accepted: 2017/10/30 | ePublished: 2017/10/30

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb